Impact of price control on pharmaceutical sector with reference to India

Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; Jagtap, Aishwarya

doi:10.1504/ijie.2021.112324

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The strict Indian regulation to decrease the prices of medicines has contributed to reducing the total cost of healthcare in India, with larger numbers of essential drugs coming under the price ceiling every day (Kolte, Mal, Fulambrikar, & Jagtap, 2020). Hence, there has been a greater penetration of drugs in middle‐income groups that require drugs for various treatments.…”

Section: Results Discussionmentioning

confidence: 99%

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

Kolte

Festa

Rossi

et al. 2022

Thunderbird Intl Bus Rev

Self Cite

View full text Add to dashboard Cite

This study investigates the influence that business ambidexterity of the Indian pharmaceutical industry can exert on exports, after the evolution from producer—often with the support of foreign direct investments (FDIs)—to researcher. The growth rate of the sector has changed pace with the introduction of new rules regarding patents, impelling pharma enterprises to invest in research and development (R&D), also for the peculiar category of AYUSH. However, many aspects of this industrial evolution are, if anything, under researched. To fill this gap in knowledge, this research adopts a quantitative methodology on secondary data to investigate the effects and potentialities of ambidexterity, providing evidence from descriptive and inferential statistics. Insisting on traditional production of generics (exploitation) and investing in R&D (exploration) have been coherent with the rise in exports, but several factors still impede the development of the commercial potential of the Indian pharmaceutical industry, mostly due to low per capita health care spending, absence of reliable infrastructure, and severe market competition.

show abstract

Section: Results Discussionmentioning

confidence: 99%

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

Kolte

Festa

Rossi

et al. 2022

Thunderbird Intl Bus Rev

Self Cite

View full text Add to dashboard Cite

show abstract

“…PPP identifies persons, groups and organizations that perform practices specific to a particular context in a digital health innovation ecosystem Operation with small and big entrepreneurs is an effective way to achieve foreign markets quicker or at less expense as a result of independent growth (Dana, 2000; Ferreira and Dana, 2017; Kolte et al , 2021b). The stakeholders like government (Public), Private organization partnership can alliance to serve health services (Kolte et al , 2021a). Through PPP in the digital health innovation ecosystem should formally record the identified objectives at an early stage for better delivery of digital health services.…”

Section: Proposed Modelmentioning

confidence: 99%

“…The stakeholders like government (Public), Private organization partnership can alliance to serve health services (Kolte et al, 2021a). Through PPP in the digital health innovation ecosystem should formally record the identified objectives at an early stage for better delivery of digital health services.…”

Section: Proposed Modelmentioning

confidence: 99%

A study on entrepreneurial opportunities in digital health-care post-Covid-19 from the perspective of developing countries

Khandelwal

Kolte

Rossi

2021

Self Cite

View full text Add to dashboard Cite

Purpose The Covid-19 pandemic encourages organized structures across health sectors to react to the outbreak and digital health technologies have been identified as promising pillars to respond to the outbreak across the globe. The purpose of this study is to address the scoping review aimed at identifying the innovative entrepreneurial opportunities in digital health-care ecosystems. The study highlights the barriers to digital health in developing countries. The study is a forum for the introduction of entrepreneurship prospects in the Indian sense through other foreign readers in developing countries. Design/methodology/approach This archival study highlights topical literature to explore successful ways of improving market potential in developed countries with respect to digital health. The research offers insights into how a digital health environment could be applied, provides a trajectory that concentrates on key skills and a creative approach. Findings Health service providers require developing their competency and skills to accelerate and enhance their entrepreneurial opportunities. Social network dynamics analyzes are particularly helpful in modeling pandemic trends and in tracking post-pandemic digital health needs. The acceptability of digital solutions has to be confronted across developing countries especially in rural areas and a collective public health benefit in form of entrepreneurship to serve the society. Research limitations/implications The research temporarily indicates a creative solution to entrepreneurship in developed countries that can be applied in today’s digital arena. Originality/value To raise public understanding of the advantages of digital health systems in developed regions, health education and promotion campaigns should be focused. The idea analysis can be useful benchmarks for policymakers rather than digital health jurisdictions. The post-pandemic provides developed countries a great opportunity for advanced technology to expand connectivity and networking to digital health entrepreneurship.

show abstract

Impact of price control on pharmaceutical sector with reference to India

Cited by 2 publications

References 0 publications

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry

A study on entrepreneurial opportunities in digital health-care post-Covid-19 from the perspective of developing countries

Contact Info

Product

Resources

About